Immune Modulators as Therapeutic Agents for Cutaneous T-Cell Lymphoma

Cutaneous T-cell lymphoma at all stages appears to be responsive to immune modulatory therapeutic approaches. We describe here the mechanistic rationale for the use of interferons, interleukin-12, retinoids, Toll-like receptor agonists, photopheresis and combinations of immune preserving, immune sti...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Rook, Alain H., Benoit, Bernice, Kim, Ellen J., Vittorio, Carmela C., Anshelevich, Sasha, Raphael, Brian A., Introcaso, Camille E., Gardner, Jennifer M., Evans, Katherine G., Morrissey, Kelly, Samimi, Sara, Musiek, Amy C., Showe, Louise C., Wasik, Mariusz A., Wysocka, Maria
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3877673/
https://ncbi.nlm.nih.gov/pubmed/20826407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3816/CLML.2010.s.017
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller